Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6803116 | 0.81 | MEN1 (0.40) | MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL24427305 | 0.79 | MEN1 (0.38) | MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL24427550 | 0.73 | CYP2A6 (0.35) | — | |
| SCHEMBL10367117 | 0.71 | MEN1 (0.38) | MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL24427304 | 0.70 | MEN1 (0.48) | MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL31705532 | 0.68 | NOTUM (0.46) | — | |
| SCHEMBL12124201 | 0.68 | — | — | |
| SCHEMBL16746090 | 0.66 | MEN1 (0.36) | MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL24427706 | 0.64 | AR (0.43) | ALDH1A1GAA | |
| SCHEMBL5638815 | 0.64 | MEN1 (0.38) | MEN1ALDH1A1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11518766-B2 | Tricyclic compound, preparation method therefor and use thereof | SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD. (CN) | 2022-12-06 | — | — | US | disclosed |
| EP-3998263-A1 | TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Jemincare Pharmaceuticals Co., Ltd. (CN) | 2022-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11518766-B2 | Tricyclic compound, preparation method therefor and use thereof | TFPI, TFPI2, F11 | MEN1 431/4885ALDH1A1 3573/4885GAA 1698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.